Systemic drugs	treat	obstructive airway diseases
Obstructive airway diseases	include	asthma
Obstructive airway diseases	include	COPD
Systemic drugs	classified by	ATC
ATC	codes	R03
R03	includes	systemic drugs
Systemic drugs	include	corticosteroids
Corticosteroids	used for	inflammation
Corticosteroids	reduce	airway hyperresponsiveness
Corticosteroids	administered	orally
Corticosteroids	administered	intravenously
Corticosteroids	administered	intramuscularly
Corticosteroids	side effect	adrenal suppression
Corticosteroids	side effect	osteoporosis
Corticosteroids	side effect	hyperglycemia
Corticosteroids	side effect	weight gain
Corticosteroids	side effect	mood changes
Corticosteroids	contraindicated	pregnancy
Corticosteroids	contraindicated	uncontrolled infection
Corticosteroids	dosage	depends on severity
Corticosteroids	tapering	required
Systemic drugs	include	leukotriene modifiers
Leukotriene modifiers	used for	asthma
Leukotriene modifiers	reduce	bronchoconstriction
Leukotriene modifiers	side effect	headache
Leukotriene modifiers	side effect	abdominal pain
Leukotriene modifiers	contraindicated	hepatic impairment
Systemic drugs	include	theophylline
Theophylline	mechanism	phosphodiesterase inhibition
Theophylline	mechanism	adenosine receptor antagonism
Theophylline	side effect	nausea
Theophylline	side effect	arrhythmia
Theophylline	side effect	seizures
Theophylline	requires	therapeutic drug monitoring
Systemic drugs	include	antihistamines
Antihistamines	used for	allergic asthma
Antihistamines	side effect	sedation
Antihistamines	side effect	dry mouth
Antihistamines	contraindicated	severe renal impairment
Systemic drugs	include	immunomodulators
Immunomodulators	include	omalizumab
Omalizumab	target	IgE
Omalizumab	used for	severe allergic asthma
Omalizumab	side effect	anaphylaxis
Omalizumab	side effect	injection site reaction
Immunomodulators	include	mepolizumab
Mepolizumab	target	IL‑5
Mepolizumab	used for	eosinophilic asthma
Mepolizumab	side effect	headache
Mepolizumab	side effect	injection site pain
Immunomodulators	include	benralizumab
Benralizumab	target	IL‑5 receptor
Benralizumab	used for	severe eosinophilic asthma
Benralizumab	side effect	fatigue
Benralizumab	side effect	nasopharyngitis
Immunomodulators	include	dupilumab
Dupilumab	target	IL‑4 receptor
Dupilumab	used for	atopic dermatitis
Dupilumab	used for	asthma
Dupilumab	side effect	conjunctivitis
Dupilumab	side effect	injection site reaction
Systemic drugs	include	macrolide antibiotics
Macrolide antibiotics	used for	COPD exacerbation
Macrolide antibiotics	mechanism	anti‑inflammatory
Macrolide antibiotics	side effect	QT prolongation
Macrolide antibiotics	side effect	diarrhea
Systemic drugs	include	beta‑agonists
Beta‑agonists	used for	acute bronchospasm
Beta‑agonists	side effect	tremor
Beta‑agonists	side effect	tachycardia
Beta‑agonists	contraindicated	uncontrolled arrhythmia
Systemic drugs	include	anticholinergics
Anticholinergics	used for	COPD
Anticholinergics	side effect	dry mouth
Anticholinergics	side effect	urinary retention
Systemic drugs	include	phosphodiesterase‑4 inhibitors
Phosphodiesterase‑4 inhibitors	include	roflumilast
Roflumilast	used for	severe COPD
Roflumilast	side effect	diarrhea
Roflumilast	side effect	weight loss
Systemic drugs	include	biologic agents
Biologic agents	include	tezepelumab
Tezepelumab	target	TSLP
Tezepelumab	used for	severe asthma
Tezepelumab	side effect	nasopharyngitis
Biologic agents	include	reslizumab
Reslizumab	target	IL‑5
Reslizumab	used for	eosinophilic asthma
Reslizumab	side effect	headache
Biologic agents	include	tralokinumab
Tralokinumab	target	IL‑13
Tralokinumab	used for	asthma
Tralokinumab	side effect	injection site reaction
Biologic agents	include	lebrikizumab
Lebrikizumab	target	IL‑13
Lebrikizumab	used for	asthma
Lebrikizumab	side effect	conjunctivitis
Systemic drugs	include	oral retinoids
Oral retinoids	used for	severe asthma
Oral retinoids	side effect	teratogenicity
